Martina Ubaldi

机构：University of Perugia, Azienda Ospedaliera di Perugia, Ospedale Santa Maria · ORCID：0009-0004-9453-5555

发表论文 17 篇 · 总被引 83 次 · h-index 5

代表论文

• Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study (2023 · EClinicalMedicine · 被引 27)
• Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study) (2024 · European Journal of Cancer · 被引 21)
• Circulating hsa-miR-323b-3p in Huntington's Disease: A Pilot Study (2021 · Frontiers in Neurology · 被引 17)
• Emerging Predictive Biomarkers of Immunotherapy Sensitivity in Patients with Non-Small Cell Lung Cancer (2026 · ImmunoTargets and Therapy · 被引 5)
• Transbronchial Mediastinal Cryobiopsy Guided by Endobronchial Ultrasound in Addition to Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Diagnosis of Ilo-Mediastinal Lymphadenopathy Without Obvious Primary Lung Neoplastic Lesion: A Prospective Multicenter Study (2025 · Journal of Clinical Medicine · 被引 5)
• Tracking and tackling the tumor dynamics clonal evolution: osimertinib rechallenge after interval therapy might be an effective treatment approach in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) (2022 · Journal of Thoracic Disease · 被引 5)